April 2024.

Listen here:

And available everywhere you listen to podcasts: https://pod.link/thehealthyhandful

About this episode

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing across the globe.

Here in Australia, it affects two in five adults. NAFLD is fast becoming a significant public health concern in western countries, including Australia, particularly as it’s also the main cause of chronic liver disease.

So, what does the evidence say in terms of prevention and treatment of this disease?

Join me as I speak with Senior Lecturer at Monash University, Dr Barbara Cardoso, to learn more.

We discuss her latest research findings, including the role of the Mediterranean diet, and just how crucial diet is in helping to reduce the risk of NAFLD.

About today’s guest

Dr Barbara Cardoso is an internationally-recognised nutritional biochemist and holds a Senior Lecturer position in the Department of Nutrition, Dietetics and Food at Monash University. 

Her research encompasses trials and epidemiological analysis to unravel how including nuts as part of a regular diet can mitigate cognitive decline in high-risk populations.

Dr Cardoso is listed in the top 1% worldwide for expertise on nuts (0.52%).

Supporting resources:

Effect of nut consumption on non-alcoholic fatty liver disease: A systematic review and meta-analysis

Intake of nuts and seeds is associated with a lower prevalence of non-alcoholic fatty liver disease in US Adults: Findings from 2005–2018 NHANES

Associations between nut intake, cognitive function and non-alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14

Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease

Sign up to NutENews

Follow us on Instagram, Twitter, Facebook and LinkedIn

Credits

Host: Belinda Neville

Contact us admin@nutsforlife.com.au